Bjerre

About Steen Bjerre

This author has not yet filled in any details.
So far Steen Bjerre has created 190 blog entries.

Get your website hosted at haei.org

2018-04-07T14:29:30+00:00

A growing number of national HAE organizations have their own websites with their own individual hosting solution. However, some of them would like to change hosting or altogether change the look and content of their websites. And others would like to just have a website at all. “In order to accommodate any such national HAE [...]

HAEi Jakobsweg Walk 2018

2018-04-07T14:23:46+00:00

After the successful HAEi/AEDAF Camino Walk on the Camino de Santiago in northwestern Spain in May 2016 and May 2017, HAEi is organizing yet another walk. In order to raise awareness, HAEi brings together HAE friends — patients, relatives, caregivers, doctors, nurses, and industry — for the HAEi Jakobsweg Walk 2018. Just as for the [...]

2017 revision and update of the international WAO/EAACI guideline for the management of HAE

2018-04-07T14:21:11+00:00

An international expert panel has reviewed the existing evidence and developed 20 recommendations that were discussed, finalized and consented during the guideline consensus conference in 2016 in Vienna, Austria. The final version of this update and revision of the guideline incorporates the contributions of a board of expert reviewers and the endorsing societies. The goal [...]

Two decades with AEDAF in Spain

2018-04-07T14:17:54+00:00

Asociación Española de Angioedema Familiar por Deficiencia del Inhibidor de C1 – or in short AEDAF – held its 20th Annual Meeting and General Assembly in Madrid Saturday 10 March 2018. Dr. Teresa Caballero Molina opened the meeting, taking place at Hospital Universitario La Paz. After the 2017 Activities Report presented by the AEDAF President [...]

Potentially 28,000 HAE patients in China

2018-04-07T14:16:16+00:00

By Fiona Wardman, HAEi Executive Committee member and President of HAE Australasia China has a population of approximately 1.4 billion, which means there are potentially 28,000 patients with HAE in this huge country. Based on these numbers there is only a small percentage of patients already diagnosed and being treated by knowledgeable physicians. At this [...]

Thousands will help raise HAE awareness step by step

2018-03-31T18:04:04+00:00

On and around hae day :-) 2018 a group of HAE patients, relatives, caregivers, doctors, nurses, people from HAE organizations, and industry will walk four stages of the Jakobsweg through Vienna, Austria. Jakobsweg is German for “The Way of St. James” – the pilgrimage route through the Austrian capital and connected to other pilgrimage routes leading [...]

Regulatory Milestones for Investigational HAE Treatment Lanadelumab

2018-03-30T12:55:22+00:00

The European Medicines Agency (EMA) has validated its marketing authorization application (MAA) for Lanadelumab (SHP643) from Shire plc - and Health Canada has completed screening and accepted the New Drug Submission (NDS) under Priority Review for this investigational compound. Lanadelumab is an investigational treatment being evaluated for the prevention of angioedema attacks in patients 12 [...]

HAEi magazine #1/2018 out now

2018-03-29T11:45:10+00:00

April is approaching fast, and so is the 2018 HAE Global Conference in Vienna, Austria. Therefore we publish the first issue of the HAEi magazine ”Global Perspectives” where you, among many other topics, will find articles on: News from the HAEi Regional Patient Advocates Potentially 28,000 HAE Patients in China Two Decades With AEDAF in Spain [...]

KalVista Reports Fiscal Third Quarter Results

2018-03-16T14:51:36+00:00

KalVista Pharmaceuticals, Inc. reports operational and financial results for the fiscal third quarter ended 31 January 2018. “We are pleased to have the second candidate from our oral HAE portfolio in a Phase 1 trial as we continue to pursue a best-in-class therapy,” said Andrew Crockett, CEO of KalVista. KalVista has announced the initiation of a Phase 1 [...]